Shuttle Pharmaceuticals Holdings (SHPH) Income towards Parent Company (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Income towards Parent Company history runs 6 years deep, the most recent figure standing at -$2.5 million for Q1 2026.

• On a quarterly basis, Income towards Parent Company rose 20.14% year-over-year to -$2.5 million in Q1 2026; TTM through Mar 2026 was -$11.9 million, a 18.87% decrease from a year earlier, with the FY2025 full-year figure at -$19.7 million, down 54.97% from the prior year.
• Income towards Parent Company rose to -$2.5 million in Q1 2026 per SHPH's latest filing, from -$2.8 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at -$368462.0 in Q2 2022 and bottomed at -$4.2 million in Q2 2025.
• The 5-year median for Income towards Parent Company is -$2.0 million (2023), against an average of -$2.1 million.
• Across the five-year window, Income towards Parent Company slumped 492.21% in 2022 and advanced 27.16% in 2025, its largest moves.
• Year by year, Income towards Parent Company stood at -$2.7 million in 2022, then advanced by 19.01% to -$2.2 million in 2023, then climbed by 22.51% to -$1.7 million in 2024, then sank by 63.39% to -$2.8 million in 2025, then climbed by 9.72% to -$2.5 million in 2026.
• Per Business Quant, the three latest SHPH Income towards Parent Company figures stand at -$2.5 million (Q1 2026), -$2.8 million (Q4 2025), and -$2.4 million (Q3 2025).